Literature DB >> 23381594

Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Pupalan Iyngkaran1, Merlin Thomas, William Majoni, Nagesh S Anavekar, Claudio Ronco.   

Abstract

Heart failure mortality is significantly increased in patients with baseline renal impairment and those with underlying heart failure who subsequently develop renal dysfunction. This accelerated progression occurs independent of the cause or grade of renal dysfunction and baseline risk factors. Recent large prospective databases have highlighted the depth of the current problem, while longitudinal population studies support an increasing disease burden. We have extensively reviewed the epidemiological and therapeutic data among these patients. The evidence points to a progression of heart failure early in renal impairment, even in the albuminuric stage. The data also support poor prescription of prognostic therapies. As renal function is the most important prognostic factor in heart failure, it is important to establish the current understanding of the disease burden and the therapeutic implications.

Entities:  

Year:  2012        PMID: 23381594      PMCID: PMC3551393          DOI: 10.1159/000342487

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  125 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

2.  Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure.

Authors:  Harini Chittineni; Nobuyuki Miyawaki; Sailaja Gulipelli; Steven Fishbane
Journal:  Am J Nephrol       Date:  2007-01-24       Impact factor: 3.754

3.  Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?

Authors:  Mark O Goodarzi; Bruce M Psaty
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

4.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 5.  Pharmacologic management of the cardiorenal syndrome in heart failure.

Authors:  Henry Krum; Pupalan Iyngkaran; Suree Lekawanvijit
Journal:  Curr Heart Fail Rep       Date:  2009-06

6.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

7.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

8.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

9.  Acetaminophen, aspirin and progression of advanced chronic kidney disease.

Authors:  Marie Evans; Carl Michael Fored; Rino Bellocco; Garrett Fitzmaurice; Jon P Fryzek; Joseph K McLaughlin; Olof Nyrén; Carl-Gustaf Elinder
Journal:  Nephrol Dial Transplant       Date:  2009-01-20       Impact factor: 5.992

Review 10.  Defining acute kidney injury: what is the most appropriate metric?

Authors:  Richard Solomon; Alan Segal
Journal:  Nat Clin Pract Nephrol       Date:  2008-02-05
View more
  10 in total

1.  Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.

Authors:  Adam T Whaley-Connell; Javad Habibi; Annayya Aroor; Lixin Ma; Melvin R Hayden; Carlos M Ferrario; Vincent G Demarco; James R Sowers
Journal:  Metabolism       Date:  2013-09-24       Impact factor: 8.694

Review 2.  Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice.

Authors:  Pupalan Iyngkaran; Merlin Thomas; John D Horowitz; Paul Komesaroff; Michael Jelinek; David L Hare
Journal:  Curr Cardiol Rev       Date:  2021

3.  Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study.

Authors:  Cornelia Schneider; Blai Coll; Susan S Jick; Christoph R Meier
Journal:  Clin Epidemiol       Date:  2016-06-11       Impact factor: 4.790

Review 4.  A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure.

Authors:  Pupalan Iyngkaran; Samia R Toukhsati; Merlin C Thomas; Michael V Jelinek; David L Hare; John D Horowitz
Journal:  Clin Med Insights Cardiol       Date:  2016-10-12

5.  Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case-control analyses.

Authors:  Mar Martín-Pérez; Alexander Michel; Mark Ma; Luis Alberto García Rodríguez
Journal:  BMJ Open       Date:  2019-07-11       Impact factor: 2.692

6.  Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.

Authors:  Marc Evans; Angharad R Morgan; Zaheer Yousef; Gethin Ellis; Umesh Dashora; Dipesh C Patel; Pam Brown; Wasim Hanif; Johnathan N Townend; Naresh Kanumilli; Jim Moore; John P H Wilding; Stephen C Bain
Journal:  Drugs       Date:  2021-06-23       Impact factor: 9.546

Review 7.  Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.

Authors:  P Iyngkaran; M Thomas
Journal:  Clin Med Insights Cardiol       Date:  2015-08-05

8.  Northern Territory Heart Failure Initiative-Clinical Audit (NTHFI-CA)-a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale.

Authors:  Pupalan Iyngkaran; Jeff Tinsley; David Smith; Mark Haste; Kangaharan Nadarajan; Marcus Ilton; Malcolm Battersby; Simon Stewart; Alex Brown
Journal:  BMJ Open       Date:  2014-01-29       Impact factor: 2.692

Review 9.  Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome.

Authors:  Jois Preeti; Mebazaa Alexandre; Iyngkaran Pupalan; Thomas C Merlin; Ronco Claudio
Journal:  Curr Cardiol Rev       Date:  2016

Review 10.  Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines.

Authors:  Pupalan Iyngkaran; Nadarajan Kangaharan; Hendrik Zimmet; Margaret Arstall; Rob Minson; Merlin C Thomas; Peter Bergin; John Atherton; Peter MacDonald; David L Hare; John D Horowitz; Marcus Ilton
Journal:  Curr Cardiol Rev       Date:  2016
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.